Table 3 Adoption of the non-pharmaceutical intervention strategy to control COVID-19 among respondents by subgroups
Subgroup | Percentage of adoption | ARR (95%CI) | P of ARR | NNT (95%CI) |
|---|---|---|---|---|
Sex | ||||
Male vs. female | 73.4% vs. 79.1% | 5.7% (4.9–6.5%) | < 0.001 | 18 (15–20) |
Adjusted† | 73.3% vs. 79.2% | 5.9% (4.9–6.8%) | < 0.001 | 17 (15–20) |
Degree course | ||||
Undergraduate vs. postgraduate | 75.3% vs. 81.6% | 6.3% (5.0–7.5%) | < 0.001 | 16 (13–20) |
Adjusted† | 77.1% vs. 81.6% | 4.5% (2.4–6.6%) | < 0.001 | 22 (15–42) |
Primary degree | ||||
Medicine vs. other | 76.3% vs. 76.7% | 0.4% (−0.5 to 1.2%) | 0.408 | 250 (−200 to 83) |
Adjusted† | 74.9% vs. 76.7% | 1.7% (0.8–2.7%) | < 0.001 | 59 (37–125) |
Depression score | ||||
< 16 vs. ≥16 | 79.7% vs. 70.0% | 9.7% (8.8–10.5%) | < 0.001 | 10 (10–11) |
Adjusted† | 79.7% vs. 70.0% | 9.7% (8.7–10.7%) | < 0.001 | 10 (9–11) |
Anxiety score | ||||
< 50 vs. ≥50 | 76.7% vs. 48.5% | 28.1% (21.8–34.5%) | < 0.001 | 4 (3–5) |
Adjusted† | 76.6% vs. 48.5% | 28.0% (19.7–36.3%) | < 0.001 | 4 (3–5) |
Exposure | ||||
No vs. yes | 76.8% vs. 71.3% | 5.5% (3.5–7.5%) | < 0.001 | 18 (29–13) |
Adjusted† | 74.2% vs. 71.3% | 2.9% (0.2–5.6%) | < 0.001 | 34 (500–18) |